tipranavir disodium

• チプラナビル二ナトリウム

関

tipranavir

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. HIVプロテアーゼ阻害剤 hiv protease inhibitors
• 2. 抗レトロウイルス療法の潜在的副作用に関するHIV感染患者を対象としたカウンセリング counseling hiv infected patients regarding potential side effects of antiretroviral therapy
• 3. HIV薬剤耐性検査の解釈についての手引 primer on interpretation of hiv drug resistance testing
• 4. 治療経験のある薬剤耐性HIV感染患者における抗レトロウイルス療法の選択 selection of antiretroviral therapy for the treatment experienced patient with drug resistant hiv infection
• 5. HIV抗レトロウイルス療法に関する臨床試験：プロテアーゼ阻害剤 clinical trials of hiv antiretroviral therapy protease inhibitors

English Journal

• Gateways to clinical trials.

• Tomillero A1, Moral MA.
• Methods and findings in experimental and clinical pharmacology.Methods Find Exp Clin Pharmacol.2010 Dec;32(10):749-73. doi: 10.1358/mf.2010.32.10.1573763.
• Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Trials Knowledge Area of Thomson Reuters Integrity(SM), the drug discovery and development portal, http://www.thomsonr
• PMID 21225012

• Gateways to clinical trials.

• Tomillero A, Moral MA.
• Methods and findings in experimental and clinical pharmacology.Methods Find Exp Clin Pharmacol.2009 Apr;31(3):183-226.
• (+)-Dapoxetine hydrochloride, [(123)I]-BZA, 9-Aminocamptothecin; Abacavir sulfate/lamivudine, Adalimumab, Adefovir dipivoxil, Alemtuzumab, Alvocidib hydrochloride, Ambrisentan, Amsilarotene, Anacetrapib, Anakinra, Apricitabine, Aripiprazole, Arsenic trioxide, Atazanavir sulfate, Atazanavir/ritonavir
• PMID 19536362

• Gateways to clinical trials.

• Bayés M1, Rabasseda X.
• Methods and findings in experimental and clinical pharmacology.Methods Find Exp Clin Pharmacol.2008 Jan-Feb;30(1):67-99.
• Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Trials Knowledge Area of Prouse Science Integrity, the drug discovery and development portal, http://integrity.prous.
• PMID 18389098

Related Links

• Structure-based discovery of Tipranavir disodium (PNU-140690E): a ...

Biopolymers. 1999;51(1):51-8. Structure-based discovery of Tipranavir disodium (PNU-140690E): a potent, orally bioavailable, nonpeptidic HIV protease inhibitor. Thaisrivongs S, Strohbach JW. Pharmacia & Upjohn, Inc., Kalamazoo, ...

• Tipranavir - Wikipedia, the free encyclopedia

Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection and is given as two ...

---

★リンクテーブル★

リンク元	「チプラナビル」「チプラナビル二ナトリウム」

「チプラナビル」

　　[★]

英

tipranavir、tipranavir disodium

関

チプラナビル二ナトリウム

「チプラナビル二ナトリウム」

　　[★]

英

tipranavir disodium

関

チプラナビル